Supply of Ophthalmic Solution (Bulk Pharmaceutical)

The contract requires the manufacture and delivery of a hydroxypropyl methylcellulose ophthalmic solution in bulk pharmaceutical form, strictly compliant with FDA regulations and manufactured under current good manufacturing practices to meet military medical standards. The solution is intended for use by Department of Defense personnel and must adhere to exacting quality and safety protocols, including appropriate labeling for clinical and logistical handling. The product must be produced and delivered within a rapid five-day turnaround window following order placement, emphasizing just-in-time support for field and base medical operations. The place of performance is identified as JBER with a zip code of 99506-3702, indicating the designated military installation where the product will be received and distributed. The NAICS code 325412 confirms the activity as pharmaceutical and biological product manufacturing, and the solicitation is classified as a subcontract under the Medical Supply Chain Pharm FSA, managed by the Department of Defense. All responses must be submitted by the deadline of July 20, 2026, ensuring timely vendor qualification and production scheduling to maintain operational readiness.